Body composition and well-being in cancer patients on ICI therapy
Part of Cancer clinical trials.
This study looks at how body composition and emotional factors affect cancer patients receiving immune checkpoint inhibitors (ICIs). It may help understand how these factors relate to treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a CT scan of your abdomen (L3 level) before starting ICI treatment
- You do not have a severe mental health condition and can communicate clearly
- You are willing to give written consent to participate
- Your doctor has not said you are unsuitable for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people’s bodies respond to cancer immunotherapy and why some people get side effects. Your information and lab results may help improve how immunotherapy is managed in the future.
This trial looks at how well patient-recorded measurements can be used during cancer care around the time of curative-intent surgery or chemotherapy before surgery. It may help improve monitoring and decision-making during treatment.
This study looks at how immunotherapy affects the quality of life of cancer patients who also have diabetes. It aims to understand their well-being during treatment.
This study looks at how immune-related side effects happen in people treated with certain cancer immunotherapies. It also includes some healthy volunteers and people who already have similar autoimmune conditions, to better understand and compare these reactions.
This study looks at changes in thinking, behavior, and brain structure that can happen when people with cancer lose weight and appetite (called cachexia). Researchers will use questionnaires and brain scans to understand these changes, which may help improve care for people with cancer.
This is an observational study that follows adults with solid cancer who are receiving immune checkpoint inhibitor treatments. It aims to learn how these medicines are used and what outcomes may look like in everyday care.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.